IRE1α-XBP1通过限制亲白血病基因程序来保护造血干细胞和原始细胞
Brendan M Barton1,2, Francheska Son2, Akanksha Verma3
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Nature immunology
|January 9, 2025
概括
需要伊诺西的酶-1α (IRE1α) 信号保护造血干细胞 (HSPC) 免受髓性白血病的侵害,通过抑制促进癌症的基因. 这一途径起到关键的保护作用,防止急性髓性白血病 (AML) 的发展.
科学领域:
- 细胞应激反应的应激反应
- 血液形成 血液形成 血液形成
- 在瘤学瘤学.
背景情况:
- 造血干细胞 (HSPC) 面临着终身的压力,需要强大的机制来维持血液细胞的生产.
- 压力反应通路的调节失调可能会导致髓性白血病的发展.
- 展开的蛋白质反应 (UPR) 是一个关键的细胞应激管理系统.
研究的目的:
- 研究 UPR 传感器所需的内醇酶-1α (IRE1α) 在保护造血干细胞和原始细胞 (HSPCs) 免受骨髓性白血病发生的作用.
- 阐明IRE1α信号预防白血病的下游机制.
- 为了确定急性髓性白血病 (AML) 的潜在治疗点.
主要方法:
- 利用转录组分析和全基因组映射在HSPC中的X盒结合蛋白-1 (XBP1) 目标.
- 采用IRE1α缺乏和骨髓增殖性瘤基因的小鼠模型来研究AML的发展.
- 评估了XBP1诱导对白血病干细胞程序和患者衍生的AML细胞的影响.
主要成果:
- 鉴定了由NADPH氧化酶-2激活的IRE1α信号,作为HSPC中的关键调节器.
- 证明IRE1α诱导的XBP1抑制了亲白血病性程序,包括Wnt-β-catenin通路.
- 发现了XBP1-抑制的β-catenin点的"18基因特征",与AML的预后不佳有关.
- 表明IRE1α缺乏加速小鼠AML的发展,而XBP1诱导抑制白血病干细胞活性.
结论:
- IRE1α-XBP1信号传递在HSPC中起到关键的保护作用,防止骨髓性白血病发生.
- 这一途径限制了亲白血病的计划,为AML提供了一种新的治疗途径.
- 准IRE1α-XBP1轴可能有望治疗急性髓性白血病.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:28Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
01:21Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K